What is RIVANNA?
RIVANNA® is a commercial-stage medical device innovator and manufacturer headquartered in Charlottesville, VA. The company specializes in developing and commercializing world-first, imaging-based medical technologies designed to elevate global standards of care. RIVANNA provides comprehensive imaging solutions for both early- and late-stage point-of-care spinal needle interventions and musculoskeletal diagnostics, positioning itself as a key player in the medical technology sector.
How much funding has RIVANNA raised?
RIVANNA has raised a total of $4.1M across 4 funding rounds:
Private Equity
$3M
Debt
$150K
Debt
$177K
Grant
$800K
Private Equity (2016): $3M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $177K supported by PPP
Grant (2025): $800K, investors not publicly disclosed
What's next for RIVANNA?
With the recent major strategic investment and substantial overall capital, RIVANNA is well-positioned for significant growth and market expansion. The company's focus on innovative imaging technologies for critical medical interventions suggests a trajectory towards broader adoption in clinical settings. Future developments are likely to center on scaling manufacturing, further research and development into new imaging applications, and strengthening its commercial partnerships to solidify its position as a leader in advanced medical diagnostics and interventions.
See full RIVANNA company page
